Article Information
History
- March 5, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alvin Meltsov, MSca,b,
- Elisa Giacomini, PhDc,
- Paola Vigano, PhDd,
- Natasa Zarovni, PhDe,
- Andres Salumets, PhDa,f,g and
- Elina Aleksejeva, PhDa,g,*
- aCompetence Centre on Health Technologies, Tartu, Estonia
- bDepartment of Genetics and Cell Biology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands
- cReproductive Sciences Laboratory, Obstetrics and Gynaecology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
- dInfertility Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
- eHansaBioMed Life Sciences OÜ, Tallinn, Estonia
- fDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
- gDepartment of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
- ↵*Corresponding Author:
Dr. Elina Aleksejeva, Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia, L. Puusepa 8, 50406 Tartu, Estonia, +372 733 0401, elina.aleksejeva{at}ccht.ee
Authorship: A.M. did the bioinformatic analysis on data published by E.G. and P.V. E.A., A.S. and N.Z. designed the study and all authors contributed to the interpretation of data and the content of the manuscript. E.A. and A.M. prepared the manuscript.
Posted March 05, 2023.
Pilot proof for RNA biomarker-based minimally invasive endometrial receptivity testing using uterine fluid extracellular vesicles
